- Home
- HFBL vs IGC Comparison
HFBL vs IGC Comparison
Compare HFBL & IGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HFBL
- IGC
- Stock Information
- Founded
- HFBL 1924
- IGC 2005
- Country
- HFBL United States
- IGC United States
- Employees
- HFBL N/A
- IGC N/A
- Industry
- HFBL Savings Institutions
- IGC Biotechnology: Pharmaceutical Preparations
- Sector
- HFBL Finance
- IGC Health Care
- Exchange
- HFBL Nasdaq
- IGC Nasdaq
- Market Cap
- HFBL 41.6M
- IGC 33.8M
- IPO Year
- HFBL N/A
- IGC N/A
- Fundamental
- Price
- HFBL $15.25
- IGC $0.36
- Analyst Decision
- HFBL
- IGC Strong Buy
- Analyst Count
- HFBL 0
- IGC 2
- Target Price
- HFBL N/A
- IGC $4.00
- AVG Volume (30 Days)
- HFBL 2.4K
- IGC 933.0K
- Earning Date
- HFBL 10-23-2025
- IGC 11-14-2025
- Dividend Yield
- HFBL 3.54%
- IGC N/A
- EPS Growth
- HFBL 35.20
- IGC N/A
- EPS
- HFBL 1.47
- IGC N/A
- Revenue
- HFBL $21,720,000.00
- IGC $1,106,000.00
- Revenue This Year
- HFBL N/A
- IGC $3.54
- Revenue Next Year
- HFBL N/A
- IGC $15.12
- P/E Ratio
- HFBL $10.39
- IGC N/A
- Revenue Growth
- HFBL 10.10
- IGC N/A
- 52 Week Low
- HFBL $12.27
- IGC $0.25
- 52 Week High
- HFBL $16.95
- IGC $0.50
- Technical
- Relative Strength Index (RSI)
- HFBL 54.44
- IGC 37.23
- Support Level
- HFBL $15.32
- IGC $0.35
- Resistance Level
- HFBL $15.99
- IGC $0.40
- Average True Range (ATR)
- HFBL 0.25
- IGC 0.03
- MACD
- HFBL 0.02
- IGC -0.00
- Stochastic Oscillator
- HFBL 39.50
- IGC 22.64
About HFBL Home Federal Bancorp Inc. of Louisiana
Home Federal Bancorp Inc of louisiana operates as a bank holding company. It is a federally chartered stock savings bank, which provides financial services to individuals, corporate entities, and other organizations. Its core activities consist of attracting deposits from the general public and using those funds to originate loans to the residential, commercial and multi-family segments. The company also invests securities held-to-maturity and securities available for sale.
About IGC IGC Pharma Inc.
IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.